Meningococcal B (MenB) vaccination programme

Documents relating to the new meningococcal B (MenB) vaccination (Bexsero®) programme starting from 1 September 2015.

Meningococcal disease is caused by invasive infection with the bacterium Neisseria meningitidis, also known as the meningococcus.

There are 12 identified capsular groups of which groups B, C, W and Y were historically the most common in the UK.

The new MenB vaccine (Bexsero®) will protect against meningococcal disease capsular group B. The vaccine will be added to the childhood immunisation programme as part of the routine schedule in England from 1 September 2015.

Vaccine coverage estimates using a sentinel surveillance system are available


  1. MenB vaccine and paracetamol
  2. MenB and MenACWY programmes: video training guide
  3. MenB and MenACWY programmes: advanced training slides
  4. MenB immunisation programme: training and communication resources
  5. MenB vaccine: poster for hospital accident and emergency departments
  6. MenB vaccine: poster for healthcare professionals
  7. Meningococcal B and ACWY: vaccination programme monitoring
  8. MenB: protecting your baby against meningitis and septicaemia
  9. MenB: guidance for parents on meningitis and septicaemia
  10. Meningococcal B: training slideset
  11. Meningococcal B: vaccine information for healthcare professionals
  12. MenB vaccination: introduction from September 2015
Published 30 June 2015
Last updated 26 February 2016 + show all updates
  1. Addition of link to MenB vaccine coverage estimates
  2. Additional information added regarding MenB and Paracetamol
  3. Added training guide for healthcare professionals.
  4. Added 2 guides for parents on meningitis and septicaemia caused by meningococcal group B disease.
  5. First published.